Two MACSQuant Analyzer flow cytometer in a clean room used for cell analysis during cell and gene therapy manufacturing on the CliniMACS Prodigy Platform in the background
Two MACSQuant Analyzer flow cytometer in a clean room used for cell analysis during cell and gene therapy manufacturing on the CliniMACS Prodigy Platform in the background
Logo

Analytical solutions to accelerate your cell and gene therapy pipeline

Developing safe and effective cell and gene therapies (CGTs) requires robust analytical methods to ensure product quality, regulatory compliance, and streamlining commercialization. Our purpose-built CGT analytics tools support every phase, from assay development and validation to routine quality control (QC) testing. These tools help you reduce risk and accelerate your progress.

Designed around critical quality attributes (CQAs) and ICH guidelines, our integrated workflows support the precision, consistency, and compliance that your analytics require. From incoming goods, in-process controls (IPC) and release testing (RT) to exploratory research assays and beyond, our scalable solutions enable you to reach every milestone.

De-risk your analytical cell and gene therapy journey:
Ensure quality, compliance, and scalability

Scientist in research lab, doing cell analysis on a MACSQuant Analyzer flow cytometer

Design reliable assays right from the start

Accelerate CGT programs with optimized flow cytometry solutions:
  • Multiparametric MACSQuant® Analyzer with minimal downtime.
  • Extensive panel of validated and customizable REAfinity® Recombinant Antibodies.
  • Proprietary Vio® Dyes minimize spectral spillover for cleaner data.
Workflow illustration on cell and gene therapy analytics showing step 1 of 3: Flexibility and consistency in preclinical assay development, allowing transition to step 2, e.g., by IND, or CTA

Design reliable assays right from the start

Accelerate CGT programs with optimized flow cytometry solutions:
  • Multiparametric MACSQuant® Analyzer with minimal downtime.
  • Extensive panel of validated and customizable REAfinity® Recombinant Antibodies.
  • Proprietary Vio® Dyes minimize spectral spillover for cleaner data.
Scientist looking at a sample, standing in front of a flow cytometer, performing cell and gene therapy analytics on the MACSQuant Analyzer 16 flow cytomer, CliniMACS Prodigy in a clean room in the background

Streamline compliance and maximize reproducibility

Ensure data integrity and regulatory readiness:
  • 21 CFR Part 11 software with automated gating and audit trails.
  • Fully automated, from maintenance to acquisition and data analysis.
  • Quality-assured antibody cocktails (liquid & dry) reduce operator error.
Workflow illustration on cell and gene therapy analytics showing step 2 of 3: reaching audit-readiness and automation through assay validation (clinical phase 1-3), allowing transition to step 3, e.g., by BLA or MAA

Streamline compliance and maximize reproducibility

Ensure data integrity and regulatory readiness:
  • 21 CFR Part 11 software with automated gating and audit trails.
  • Fully automated, from maintenance to acquisition and data analysis.
  • Quality-assured antibody cocktails (liquid & dry) reduce operator error.
Quality control operator leaving release testing site with two flow cytometers for cell and gene therapy analytics in front of a cell factory used for cell therapy manufacturing

Scale confidently with robust analytics

Empower analytics across instruments and production sites:
  • Multi-instrument alignment for seamless assay transfer.
  • Robotic integration-ready instruments support automated workflows.
  • Expert service and training to stay productive without delays.
Workflow illustration on cell and gene therapy analytics showing step 3 of 3: reaching scalability and cost eddiciency through assay maintenance (commercialization phase)

Scale confidently with robust analytics

Empower analytics across instruments and production sites:
  • Multi-instrument alignment for seamless assay transfer.
  • Robotic integration-ready instruments support automated workflows.
  • Expert service and training to stay productive without delays.
Infographic showing the assay lifecycle from development to validation and maintenance, highlighting flexibility, automation, scalability, and cost efficiency.
Scientist in research lab, doing cell analysis on a MACSQuant Analyzer flow cytometer

Design reliable assays right from the start

Accelerate CGT programs with optimized flow cytometry solutions:
  • Multiparametric MACSQuant® Analyzer with minimal downtime.
  • Extensive panel of validated and customizable REAfinity® Recombinant Antibodies.
  • Proprietary Vio® Dyes minimize spectral spillover for cleaner data.
Workflow illustration on cell and gene therapy analytics showing step 1 of 3: Flexibility and consistency in preclinical assay development, allowing transition to step 2, e.g., by IND, or CTA

Design reliable assays right from the start

Accelerate CGT programs with optimized flow cytometry solutions:
  • Multiparametric MACSQuant® Analyzer with minimal downtime.
  • Extensive panel of validated and customizable REAfinity® Recombinant Antibodies.
  • Proprietary Vio® Dyes minimize spectral spillover for cleaner data.
Scientist looking at a sample, standing in front of a flow cytometer, performing cell and gene therapy analytics on the MACSQuant Analyzer 16 flow cytomer, CliniMACS Prodigy in a clean room in the background

Streamline compliance and maximize reproducibility

Ensure data integrity and regulatory readiness:
  • 21 CFR Part 11 software with automated gating and audit trails.
  • Fully automated, from maintenance to acquisition and data analysis.
  • Quality-assured antibody cocktails (liquid & dry) reduce operator error.
Workflow illustration on cell and gene therapy analytics showing step 2 of 3: reaching audit-readiness and automation through assay validation (clinical phase 1-3), allowing transition to step 3, e.g., by BLA or MAA

Streamline compliance and maximize reproducibility

Ensure data integrity and regulatory readiness:
  • 21 CFR Part 11 software with automated gating and audit trails.
  • Fully automated, from maintenance to acquisition and data analysis.
  • Quality-assured antibody cocktails (liquid & dry) reduce operator error.
Quality control operator leaving release testing site with two flow cytometers for cell and gene therapy analytics in front of a cell factory used for cell therapy manufacturing

Scale confidently with robust analytics

Empower analytics across instruments and production sites:
  • Multi-instrument alignment for seamless assay transfer.
  • Robotic integration-ready instruments support automated workflows.
  • Expert service and training to stay productive without delays.
Workflow illustration on cell and gene therapy analytics showing step 3 of 3: reaching scalability and cost eddiciency through assay maintenance (commercialization phase)

Scale confidently with robust analytics

Empower analytics across instruments and production sites:
  • Multi-instrument alignment for seamless assay transfer.
  • Robotic integration-ready instruments support automated workflows.
  • Expert service and training to stay productive without delays.

Optimize your analytical solutions and accelerate your results with expert guidance.

When performance and consistency make a difference

Proven tools to advance your cell and gene therapy analytics strategy

Achieve precision, compliance, and scalability with analytical tools designed for regulatory alignment and operational efficiency. Our solutions support assay validation, batch release, and product characterization, empowering you to meet milestones with speed and confidence.

Expert cell and gene therapy analytics services to streamline your path to market

Our specialists have over 30 years of experience in CGT analytics. They will partner with you to tailor analytical approaches to your requirements, reducing variability, improving assay robustness, and streamlining complex workflows. This will allow you to move forward with certainty.

CGT Hospital Network Visual Purple and Blue Background

Expert insights into CGT analytics

Explore webinars, expert discussions, and practical resources on analytical development, assay validation, and quality control throughout the CGT lifecycle.

Optimize your analytical solutions and accelerate your results with expert guidance